Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
Clinical trial NCT01073436 · TERMINATED
Trial details
- NCT number
- NCT01073436
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.